Update Alert 3: Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults.

Mackey, Katherine; Kansagara, Devan; Vela, Kathryn

Mackey, Katherine; Kansagara, Devan; Vela, Kathryn.

Mackey K; VA Portland Health Care System, Portland, Oregon (K.M., D.K., K.V.).
Kansagara D; VA Portland Health Care System, Portland, Oregon (K.M., D.K., K.V.).
Vela K; VA Portland Health Care System, Portland, Oregon (K.M., D.K., K.V.).

Ann Intern Med ; 173(7): 130-131, 2020 10 06.

Article in English | MEDLINE | ID: covidwho-2110779

Subject(s)

Coronavirus Infections; Pandemics; Pneumonia, Viral; Severe Acute Respiratory Syndrome; Adult; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Angiotensins; Betacoronavirus; COVID-19; Coronavirus Infections/epidemiology; Humans; Pneumonia, Viral/epidemiology; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Severe Acute Respiratory Syndrome / Pandemics Type of study: Experimental Studies / Observational study / Prognostic study Limits: Adult / Humans Language: English Journal: Ann Intern Med Year: 2020 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google